Trial Profile
A randomized, double-blind, placebo-controlled, phase II study of Org 3770 (mirtazapine) in the treatment of patients with fibromyalgia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Mar 2017
Price :
$35
*
At a glance
- Drugs Mirtazapine (Primary)
- Indications Fibromyalgia
- Focus Therapeutic Use
- Sponsors Meiji Seika Pharma
- 19 Jan 2015 New trial record